BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 26689875)

  • 81. Clinical and Laboratory Factors Affecting the Prognosis of Severe Combined Immunodeficiency.
    Ozturk E; Catak MC; Kiykim A; Baser D; Bilgic Eltan S; Yalcin K; Kasap N; Nain E; Bulutoglu A; Akgun G; Can Y; Sefer AP; Babayeva R; Caki-Kilic S; Tezcan Karasu G; Yesilipek A; Ozen A; Karakoc-Aydiner E; Baris S
    J Clin Immunol; 2022 Jul; 42(5):1036-1050. PubMed ID: 35451701
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Omenn syndrome does not live by V(D)J recombination alone.
    Marrella V; Maina V; Villa A
    Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):525-31. PubMed ID: 22001740
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Generation of recombination activating gene-1-deficient neonatal piglets: a model of T and B cell deficient severe combined immune deficiency.
    Ito T; Sendai Y; Yamazaki S; Seki-Soma M; Hirose K; Watanabe M; Fukawa K; Nakauchi H
    PLoS One; 2014; 9(12):e113833. PubMed ID: 25437445
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Patients with T⁺/low NK⁺ IL-2 receptor γ chain deficiency have differentially-impaired cytokine signaling resulting in severe combined immunodeficiency.
    Fuchs S; Rensing-Ehl A; Erlacher M; Vraetz T; Hartjes L; Janda A; Rizzi M; Lorenz MR; Gilmour K; de Saint-Basile G; Roifman CM; Cheuk S; Gennery A; Thrasher AJ; Fuchs I; Schwarz K; Speckmann C; Ehl S
    Eur J Immunol; 2014 Oct; 44(10):3129-40. PubMed ID: 25042067
    [TBL] [Abstract][Full Text] [Related]  

  • 85. RAG mutations in human B cell-negative SCID.
    Schwarz K; Gauss GH; Ludwig L; Pannicke U; Li Z; Lindner D; Friedrich W; Seger RA; Hansen-Hagge TE; Desiderio S; Lieber MR; Bartram CR
    Science; 1996 Oct; 274(5284):97-9. PubMed ID: 8810255
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Omenn syndrome caused by a novel homozygous mutation in recombination activating gene 1.
    Benhsaien I; Essadssi S; Elkhattabi L; Bakhchane A; Abdelghaffar H; Bousfiha AA; Badou A; Barakat A
    Immunobiology; 2021 May; 226(3):152090. PubMed ID: 33964732
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Compound heterozygous DCLRE1C mutations lead to clinically typical Severe Combined Immunodeficiency presenting with Graft Versus Host Disease.
    Mou W; Gao L; He J; Yin J; Xu B; Gui J
    Immunogenetics; 2021 Dec; 73(6):425-434. PubMed ID: 34406419
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Agammaglobulinemia associated to nasal polyposis due to a hypomorphic RAG1 mutation in a 12 years old boy.
    Cifaldi C; Scarselli A; Petricone D; Di Cesare S; Chiriaco M; Claps A; Rossi P; Calzoni E; Yamazaki Y; Notarangelo LD; Di Matteo G; Cancrini C; Finocchi A
    Clin Immunol; 2016 Dec; 173():121-123. PubMed ID: 27713031
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Omenn syndrome with mutation in RAG1 gene.
    Jaouad IC; Ouldim K; Ali Ou Alla S; Kriouile Y; Villa A; Sefiani A
    Indian J Pediatr; 2008 Sep; 75(9):944-6. PubMed ID: 19011808
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Defining combined immunodeficiency.
    Roifman CM; Somech R; Kavadas F; Pires L; Nahum A; Dalal I; Grunebaum E
    J Allergy Clin Immunol; 2012 Jul; 130(1):177-83. PubMed ID: 22664165
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Immune dysregulation in patients with RAG deficiency and other forms of combined immune deficiency.
    Delmonte OM; Villa A; Notarangelo LD
    Blood; 2020 Feb; 135(9):610-619. PubMed ID: 31942628
    [TBL] [Abstract][Full Text] [Related]  

  • 92. RAG1 deficiency may present clinically as selective IgA deficiency.
    Kato T; Crestani E; Kamae C; Honma K; Yokosuka T; Ikegawa T; Nishida N; Kanegane H; Wada T; Yachie A; Ohara O; Morio T; Notarangelo LD; Imai K; Nonoyama S
    J Clin Immunol; 2015 Apr; 35(3):280-8. PubMed ID: 25739914
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Recombinase Activating Gene 1 Deficiencies Without Omenn Syndrome May Also Present With Eosinophilia and Bone Marrow Fibrosis.
    Ulusoy E; Karaca NE; Azarsiz E; Berdeli A; Aksu G; Kutukculer N
    J Clin Med Res; 2016 May; 8(5):379-84. PubMed ID: 27081423
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Evaluation of RAG1 mutations in an adult with combined immunodeficiency and progressive multifocal leukoencephalopathy.
    Schröder C; Baerlecken NT; Pannicke U; Dörk T; Witte T; Jacobs R; Stoll M; Schwarz K; Grimbacher B; Schmidt RE; Atschekzei F
    Clin Immunol; 2017 Jun; 179():1-7. PubMed ID: 28216420
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Deep intronic mis-splicing mutation in JAK3 gene underlies T-B+NK- severe combined immunodeficiency phenotype.
    Stepensky P; Keller B; Shamriz O; NaserEddin A; Rumman N; Weintraub M; Warnatz K; Elpeleg O; Barak Y
    Clin Immunol; 2016 Feb; 163():91-5. PubMed ID: 26769277
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Efficacy of lentivirus-mediated gene therapy in an Omenn syndrome recombination-activating gene 2 mouse model is not hindered by inflammation and immune dysregulation.
    Capo V; Castiello MC; Fontana E; Penna S; Bosticardo M; Draghici E; Poliani LP; Sergi Sergi L; Rigoni R; Cassani B; Zanussi M; Carrera P; Uva P; Dobbs K; Sacchetti N; Notarangelo LD; van Til NP; Wagemaker G; Villa A
    J Allergy Clin Immunol; 2018 Sep; 142(3):928-941.e8. PubMed ID: 29241731
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The genetic and biochemical basis of Omenn syndrome.
    Santagata S; Villa A; Sobacchi C; Cortes P; Vezzoni P
    Immunol Rev; 2000 Dec; 178():64-74. PubMed ID: 11213808
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Characterization of immune function and analysis of RAG gene mutations in Omenn syndrome and related disorders.
    Wada T; Takei K; Kudo M; Shimura S; Kasahara Y; Koizumi S; Kawa-Ha K; Ishida Y; Imashuku S; Seki H; Yachie A
    Clin Exp Immunol; 2000 Jan; 119(1):148-55. PubMed ID: 10606976
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Severe combined immunodeficiency (SCID): from molecular basis to clinical management.
    Sponzilli I; Notarangelo LD
    Acta Biomed; 2011 Apr; 82(1):5-13. PubMed ID: 22069950
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Novel RAG2 mutation in a patient with T- B- severe combined immunodeficiency and disseminated BCG disease.
    Sadeghi-Shabestari M; Vesal S; Jabbarpour-Bonyadi M; de Villatay JP; Fischer A; Rezaei N
    J Investig Allergol Clin Immunol; 2009; 19(6):494-6. PubMed ID: 20128425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.